Asthma

Asthma is a condition that affects many different people. In fact, around 25 million people have asthma in the U.S. alone. This means it affects 1 in every 13 people.  With this many people dealing with asthma, it makes sense to worry about how it is caused. Is it genetic? Is it due to the...

People often use the term asthma to describe something they think is a single condition. However, there are different types of asthma out there that affect the body in different ways.  One of these is eosinophilic asthma. This particularly troubling form of asthma presents a serious problem to the people with it and to healthcare...

While the Dyson high-efficiency particulate air purifier significantly improved air quality, the device did not yield any significant outcomes in lung function measures, asthma control, or quality of life, in this study. Emerging evidence supports the association between air pollution and poor asthma outcomes. While the efficacy of high-efficiency particulate air purifiers and related devices...

Omalizumab appears to be effective in reducing exacerbations and improving lung function, and it may also allow patients to reduce their inhaled corticosteroid dose. Asthma is a highly prevalent respiratory disease affecting millions of people globally. While asthma is typically considered a childhood-onset illness, onset during adolescence and adulthood is also possible. Early-onset asthma (ages...

Pomegranate extract supplementation improves spirometry test results in mild asthma patients Asthma is a complex respiratory disease affecting over 300 million people globally. It is caused by a combination of environmental exposure, genetic susceptibility, and host factors, leading to inflammation, airway obstruction, and excessive mucus production. Cytokines and inflammatory mediators contribute to airway inflammation, accompanied...

Length of stay is one way to determine the quality of care that patients have access to, and this study focuses on comparing length of stay across racial disparities for various pediatric conditions, including asthma. Inequities in childhood disease can manifest in a number of ways, and tend to be disparate across racial, ethnic, and...

Intravenous dexamethasone and methylprednisolone treatments for children with critical asthma in the PICU yielded no significant differences in clinical efficacy and safety. Dexamethasone may have potential advantages, such as a shorter corticosteroid exposure duration and less reliance on prescribed corticosteroids at discharge, which merit additional investigation. Childhood asthma affects approximately 5.1 million children in the...

There is a high prevalence of cardiovascular disease risk factors across low- and middle-income groups compared to high-income groups, reflecting cardiovascular health inequality in the young working-age population based on income levels. The income of an individual is an important social determinant of his or her cardiovascular health; however, there is limited evidence to support...

Incorrect inhaler use in children with asthma leads to worsened symptoms, but better education and community programs can mitigate these consequences. Community programs can decrease healthcare disparities and ensure all children have access to proper asthma care. Inhalers for asthma are often used incorrectly, leading to worsened symptoms and side effects. Educating children and their...